About the TrialUpdates

Updates

Arizona Kidney Disease & Hypertension Center
Mar 14, 2024Thank you and congratulations to Shouwen Wang, MD, PhD, FASN and the fantastic team at the Arizona Kidney Disease & Hypertension Center for their first randomization in the SAVE-FistulaS Clinical Trial!
Medical University of South Carolina
Mar 5, 2024A huge thank you and congratulations to the Medical University of South Carolina, Mark J. London, MD, and Faren M. Stroman, NP for their first randomization in the SAVE-FistulaS clinical trial!
Cardiothoracic and Vascular Surgeons
Feb 9, 2024A big congratulations and thank you to Dr. Ryan Turley, Shir Yelovitch, Delicia Valentin and the team at Cardiothoracic and Vascular Surgeons of Central Texas for their first randomization in the SAVE-FistulaS Clinical Trial!
Surgical Specialists of Charlotte
Feb 1, 2024Congratulations to Jason Burgess, MD and the Surgical Specialists of Charlotte, P.A. for the very first randomization of the SAVE-FistulaS Trial. What a fantastic team and site.
VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
Jan 30, 2024
VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
clinicaltrials.gov: NCT06001827

SelfWrap is currently in the research and development phase and is not available for sale in any country. Investigational device. Limited by federal law to investigational use.

© 2024 VenoStent, Inc. All rights reserved.